GR1000876B - Νεα πολυπεπτιδια που δρουν ως παραγοντες αναπτυξης και αλληλουχιες νουκλεινικων οξεων που κωδικοποιοουν τα πολυπεπτιδια - Google Patents

Νεα πολυπεπτιδια που δρουν ως παραγοντες αναπτυξης και αλληλουχιες νουκλεινικων οξεων που κωδικοποιοουν τα πολυπεπτιδια

Info

Publication number
GR1000876B
GR1000876B GR890100185A GR890100185A GR1000876B GR 1000876 B GR1000876 B GR 1000876B GR 890100185 A GR890100185 A GR 890100185A GR 890100185 A GR890100185 A GR 890100185A GR 1000876 B GR1000876 B GR 1000876B
Authority
GR
Greece
Prior art keywords
polypeptides
growth factor
nucleic acid
acid sequences
sequences encoding
Prior art date
Application number
GR890100185A
Other languages
English (en)
Other versions
GR890100185A (en
Inventor
P Joseph Brown
A Bruce Gregory
Shiu-Lok Hu
Hans Marquardt
Anthony F Purchio
Timothy M Rose
J George Todaro
R Daniel Twardzik
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of GR890100185A publication Critical patent/GR890100185A/el
Publication of GR1000876B publication Critical patent/GR1000876B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)

Abstract

Νέα πολυπεπτίδια ικανά για σύνδεση σε ένα υποδοχέα επιδερμικού παράγοντα ανάπτυξης παρέχονται, όπως επίσης πρόδρομοί τους, όπου τα πολυπεπτίδια που κωδικοποιούνται από ευλογοϊους. Οι ενώσεις έχουν ένα δομικό πλαίσιο που ειδικά περιλαμβάνει έξι κυστείνες που παρέχουν βρόχους ανάλογους με εκείνους που βρίσκονται σε φυσικά απαντώμενους παράγοντες ανάπτυξης που συνδέονται με ένα υποδοχέα παράγοντα επιδερμικής ανάπτυξης. Οι ενώσεις βρίσκουν χρήση ως μιτογόνα, προσθετικά σε μέσα θρεπτικά, σε δοκιμασίες για υποδοχείς EGF, και ως ανταγωνιστές για άλλους παράγοντες ανάπτυξης. Τα συστατικά βρίσκουν επίσης χρήση στην θεραπεία των πληγών. ω
GR890100185A 1988-03-24 1989-03-23 Νεα πολυπεπτιδια που δρουν ως παραγοντες αναπτυξης και αλληλουχιες νουκλεινικων οξεων που κωδικοποιοουν τα πολυπεπτιδια GR1000876B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17265388A 1988-03-24 1988-03-24

Publications (2)

Publication Number Publication Date
GR890100185A GR890100185A (en) 1990-01-19
GR1000876B true GR1000876B (el) 1993-03-16

Family

ID=22628611

Family Applications (1)

Application Number Title Priority Date Filing Date
GR890100185A GR1000876B (el) 1988-03-24 1989-03-23 Νεα πολυπεπτιδια που δρουν ως παραγοντες αναπτυξης και αλληλουχιες νουκλεινικων οξεων που κωδικοποιοουν τα πολυπεπτιδια

Country Status (22)

Country Link
JP (1) JPH0279981A (el)
KR (1) KR890014743A (el)
AU (2) AU3169589A (el)
BE (1) BE1004202A5 (el)
CH (1) CH681081A5 (el)
DE (1) DE3910084A1 (el)
DK (1) DK146789A (el)
ES (1) ES2013408A6 (el)
FI (1) FI891308A (el)
FR (1) FR2632321A1 (el)
GB (1) GB2219799B (el)
GR (1) GR1000876B (el)
HU (1) HUT50501A (el)
IE (1) IE890950L (el)
IL (1) IL89673A0 (el)
IT (1) IT1234961B (el)
LU (1) LU87489A1 (el)
NL (1) NL8900724A (el)
NO (1) NO891273D0 (el)
NZ (1) NZ228427A (el)
PT (1) PT90118B (el)
SE (1) SE8901031L (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293785A3 (en) * 1987-05-29 1990-05-02 Oncogen Limited Partnership Cloning and expression of simian transforming growth factor-ss1
CA2037440A1 (en) * 1990-03-02 1991-09-03 Gregory D. Plowman Her3: a novel egf receptor homolog
EP0739984A1 (en) * 1995-04-26 1996-10-30 San Tumorforschungs-Gmbh Bivalent polypeptides containing at least two domains
US6852506B1 (en) 1996-04-10 2005-02-08 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein
AU5549296A (en) * 1996-04-10 1997-10-29 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983004030A1 (en) * 1982-05-06 1983-11-24 Applied Molecular Genetics, Inc. The manufacture and expression of genes for urogastrone and polypeptide analogs thereof
JPS6028994A (ja) * 1983-07-08 1985-02-14 Wakunaga Seiyaku Kk 〔２１―ロイシン〕ヒトウロガストロン
WO1985002198A1 (en) * 1983-11-01 1985-05-23 Amgen Microbial expression of type i transforming growth factor, polypeptide analogs thereof and hybrid egf/tgf polypeptides
JP2554459B2 (ja) * 1984-07-02 1996-11-13 アース製薬 株式会社 β−ウロガストロン遺伝子、対応プラスミド組換体及び対応形質転換体
JPS62501071A (ja) * 1984-10-30 1987-04-30 オンコゲン 成長因子活性を有する新規なポリペプチド及び該ポリペプチドをコ−ドする核酸配列
GB8507666D0 (en) * 1985-03-25 1985-05-01 Wellcome Found Epidermal growth factor production
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
GB2210618B (en) * 1987-10-08 1991-10-16 British Bio Technology Synthetic egf gene
ES2081801T3 (es) * 1987-10-30 1996-03-16 Bristol Myers Squibb Co Plasmidos de expresion.
WO1989003886A1 (en) * 1987-10-30 1989-05-05 Oncogen, A Limited Partnership Expression systems for preparation of polypeptides in prokaryotic cells

Also Published As

Publication number Publication date
SE8901031D0 (sv) 1989-03-22
DE3910084A1 (de) 1989-11-16
SE8901031L (sv) 1989-09-25
FI891308A0 (fi) 1989-03-20
DK146789A (da) 1989-09-25
DK146789D0 (da) 1989-03-22
IT1234961B (it) 1992-06-09
IE890950L (en) 1989-09-24
ES2013408A6 (es) 1990-05-01
KR890014743A (ko) 1989-10-25
NZ228427A (en) 1993-03-26
PT90118A (pt) 1989-11-10
GB8906758D0 (en) 1989-05-10
NO891273D0 (no) 1989-03-22
GB2219799B (en) 1992-10-14
BE1004202A5 (fr) 1992-10-13
AU3169589A (en) 1989-09-28
NL8900724A (nl) 1989-10-16
FI891308A (fi) 1989-09-25
FR2632321A1 (fr) 1989-12-08
IT8919917A0 (it) 1989-03-24
CH681081A5 (el) 1993-01-15
IL89673A0 (en) 1989-09-28
JPH0279981A (ja) 1990-03-20
PT90118B (pt) 1994-07-29
GR890100185A (en) 1990-01-19
LU87489A1 (fr) 1989-10-26
AU2990492A (en) 1993-03-04
HUT50501A (en) 1990-02-28
GB2219799A (en) 1989-12-20

Similar Documents

Publication Publication Date Title
EP0575546A4 (en) Prad1 cyclin and its cdna
FI960888A0 (fi) Protokadheriiniproteiineja ja niiden käyttö
FI885543A0 (fi) Dna-segment, polypeptider och anti-kroppar anslutande till human vaevnadsfaktor.
ES2042861T3 (es) Procedimiento para la fabricacion de poliisocianatos modificados.
ES2169095T3 (es) Proteinas con actividad de factor viii, procedimiento para su produccion utilizando celulas modificadas por ingenieria genetica y composiciones farmaceuticas que los contienen.
PT96230A (pt) Processo para a producao de um polipeptideo e anticorpos antagonistas da interleuquina-4 humana
DE69031763D1 (de) Steigerungsverfahren der transmembranförderung von exogenen molekülen
DE68903482D1 (de) Zement, verfahren zur herstellung dieses zements und verfahren zur herstellung von produkten mit diesem zement.
EP0237966A3 (en) Human basic fibroblast growth factor
ES2073571T3 (es) Aplicacion de nuevos fragmentos de adn como secuencia que codifica un peptido señal para la secrecion de proteinas maduras, mediante levaduras recombinantes, cassettes de expresion, levaduras transformadas y procedimiento correspondiente de preparacion de proteinas.
AU2894289A (en) Domain-modified constant region antibodies
FI864016A (fi) Med rekombinant-dna-teknik erhaollen kolonistimulerande faktor-1.
DE68918556D1 (de) Bindeproteine für insulinähnliche Wachstumsfaktoren.
ES525948A0 (es) Un metodo de producir polipeptidos similares a la hormona del crecimiento porcina.
FI956057A0 (fi) Solunsisäisiä sitoutumisproteiineja (PIL) ja niiden käytöt
DE3878231D1 (de) Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
GR1000876B (el) Νεα πολυπεπτιδια που δρουν ως παραγοντες αναπτυξης και αλληλουχιες νουκλεινικων οξεων που κωδικοποιοουν τα πολυπεπτιδια
BG41137A3 (en) Method for preparing dna transfer vector for maintenance and replication of desoxynucleotide sequence coding human preproinsuline
NO882054D0 (no) Sementblanding, saerlig til bruk i borehull.
ATE109827T1 (de) Verfahren zur herstellung von peptiden, dazu zu verwendendes rekombinantes plasmid und mit diesem plasmid transformierte myelomzellen.
ES2124954T3 (es) Ciclohexapeptidos y sus mezclas, procedimiento para su preparacion asi como su empleo.
ES8707741A1 (es) Un procedimiento para prepara un polipeptido que tiene actividad de factor de crecimiento
NO941982L (no) Fremstilling av proteiner ved anvendelse av 7B2 protein